AIIMS Jammu Adv Med Unit To Boost Cancer Care

Jammu: The All-India Institute of Medical Sciences (AIIMS) Jammu on Monday launched the Centre for Advanced Genomics and Precision Medicine to boost affordable, precision-driven cancer care with advanced Next Generation Sequencing (NGS) technology.

The Centre, developed in collaboration with oncology company 4baseCare, is equipped with the Illumina NextSeq 2000 sequencing machine, offering comprehensive genomic profiling for cancer patients.

The powerful technology enables clinicians to design highly personalised, targeted treatment plans tailored to each patient’s unique molecular profile. AIIMS Jammu announced its collaboration with 4baseCare in January.

“For every patient we treat, we are treating a mother, a father, a sister, or a brother. This partnership is our promise to every family who walks through our doors that we will do everything in our power to bring them the care they deserve,” Prof (Dr) Shakti Kumar Gupta, Executive Director and CEO, AIIMS Jammu.

“By integrating cutting-edge genomic data with AI-powered diagnostics, the Centre is poised to significantly improve early disease detection, refine therapy choices, and minimise ineffective treatments -- ultimately enhancing both patient outcomes and quality of life,” said Dr Sudharshan Elangovan, Vice President – Global Operations at 4baseCare.